Biography

Aaron Devanathan received his PharmD from the University of Pittsburgh in 2016 and completed PGY1 Pharmacy Practice Residency at UNC Hospitals in 2017. He earned his PhD in Pharmaceutical Sciences at the UNC Eshelman School of Pharmacy in 2022. Since 2022, he is an Assistant Professor at the University of Pittsburgh School of Pharmacy.

His research focuses on the clinical pharmacology of antiretrovirals and their disposition into biological matrices. He also seeks to understand how antiretrovirals affect inflammatory processes related to HIV-associated comorbidities, such as cardiovascular disease and other metabolic disorders.

He is involved with numerous HIV cohorts, including the MACS/WIHS Combined Cohort Study (MWCCS) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network.

His main areas of interest are anti-infective clinical pharmacology, pharmacokinetics/pharmacodynamics/pharmacometrics, and inflammation.